24 Canadian venture capital firms investing in HealthTech / Life Sciences at Early stage. Browse their thesis focus, check sizes, and recent deals below.
Canada's Global Life Sciences Venture, sourcing promising therapeutics research from academic and biotech partners to create new companies of scale and train the next generation of life sciences leade
Early-stage biotechnology venture capital focused on the Quebec life sciences ecosystem.
Early-stage impact venture fund focused on transformational technology in Climate and Health solutions.
Toronto-based $35MM venture capital fund founded in 2022 investing in early-stage startups across AI, fintech, SaaS, healthcare, and cleantech across North America and internationally.
Focus on technology companies with validated product-market fit ready to accelerate growth. Staged strategy with discovery checks, building conviction by tracking execution.
A $100M innovative equity investment lab providing capital, training and support for 100+ ambitious women-led businesses committed to delivering measurable positive social impact tied to UN SDGs.
Companies advancing healthy aging, brain health, and dementia care.
Venture capital firm investing in high-quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and the US.
Invest in early-stage B2B enterprise software companies with clear product-market fit and strong Canadian angle.
Early-stage digital health venture fund investing in Canada and the US.
Award-winning commercialization venture firm building companies with entrepreneurs to accelerate oncology innovation, partnered with the Ontario Institute for Cancer Research (OICR).
CoFounds & Funds B2B AI-native SaaS companies with values-driven leaders.
Early-stage life science opportunities in areas of unmet medical need. Company co-creation investment strategy.
Growth capital investment firm providing private funding and merchant banking services to a wide variety of businesses at different stages of development.
Nova Scotia's early-stage venture capital organization. Provincial crown corporation building Atlantic Canada's innovation ecosystem.
Global deeptech and greentech companies reshaping legacy industries. Bridge between Canada and Asia-Pacific.
MedTech and Digital Health companies improving patient outcomes and expanding access to care.
Global venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms.
Innovative private equity fund supporting entrepreneurs and executives fostering innovation in Canada's health and wellness industry.
Focus on most common age-related conditions: brain health, diabetes, cardiovascular, mobility, respiratory, musculoskeletal.
Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.
Two themes: AI & Analytics and Disruptive HardTech. Target companies with sustainable technological advantages.
Back mission-driven founders early in new areas. Focus on crypto, deep tech, and enterprise SaaS.
Pioneered venture debt in 1980. $7.8B deployed across 1,400+ companies including Canadian firms. Now investing out of 11th institutional fund. Acquired by P10 in 2022. Flexible, founder-friendly lendi